Výsledky vyhledávání - "Natalia Logunova"

Akademický článek

Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II)

Autor: Sergey Boytsov, Natalia Logunova, Yunona Khomitskaya, on behalf of the CEPHEUS II investigators

Publikováno v: Cardiovascular Diabetology, Vol 16, Iss 1, Pp 1-11 (2017)

Abstract Background Elevated levels of low-density lipoprotein cholesterol (LDL-C) and glycosylated hemoglobin (HbA1c) are risk factors for cardiovascular complications. This study evaluated LDL-C goal attainment in Russian clinical practice among pa

Externí odkaz: https://doaj.org/article/9caadfa0be9a4f2296719b29050ed44d

Zobrazit plný text záznamu

PREDICTORS OF BISOPROLOL ON-TREATMENT STATUS AT THE TIME OF INCLUSION OF HYPERTENSIVE PATIENTS IN THE STUDY: POST-HOC ANALYSIS OF THE TRICOLOR STUDY

Autor: Natalia Logunova, Yuri Karpov, Yunona Khomitskaya

Publikováno v: Journal of Hypertension. 40:e98

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c46885b035bc2927ed17a5a5ecb1bc96
https://doi.org/10.1097/01.hjh.0000836204.43599.12

Zobrazit plný text záznamu

BASELINE CHARACTERISTICS, ANTIHYPERTENSIVE EFFECTIVENESS, AND TREATMENT ADHERENCE IN HYPERTENSIVE PATIENTS DEPENDING ON AGE: POST-HOC ANALYSIS OF THE TRICOLOR STUDY

Autor: Natalia Logunova, Yuri Karpov, Yunona Khomitskaya, Boris Kvasnikov

Publikováno v: Journal of Hypertension. 40:e98

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a4c1b8a0df0dbbc3c99d306dc32a7f8d
https://doi.org/10.1097/01.hjh.0000836200.79405.6c

Zobrazit plný text záznamu

Observational Prospective study to esTIMAte the rates of outcomes in patients undergoing PCI with drug-eluting stent implantation who take statins –follow-up (OPTIMA II)

Autor: Natalia Logunova, Buza Vv, Yu Khomitskaya, Yu Karpov, D I Tomilova

Publikováno v: Current Medical Research and Opinion. 33:253-259

The OPTIMA II study sought to evaluate rates of major adverse cardiac and cerebrovascular events (MACCEs) during the long-term follow-up of chronic statin users who underwent percutaneous coronary intervention (PCI) with implantation of a drug-elutin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb70d0adbc1ef8aa7f246c23f22d3319
https://doi.org/10.1080/03007995.2016.1253552

Zobrazit plný text záznamu